Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Engineered polypeptide-based systems can improve cancer treatment by targeting specific sites and reducing side effects.

Keratoacanthoma should be accurately diagnosed and treated based on its characteristics, often using surgery or tissue-preserving methods.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Cyproterone helps women with hair loss caused by genetics. More research is needed to confirm the best dose.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

RCDP NCs are promising anti-aging cosmetic ingredients that improve skin health by reducing oxidative stress and enhancing cell function.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

DFMO may help control hair growth and treat cancer.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

ART for HIV/AIDS can cause side effects but is crucial for managing the infection.

Clofazimine may be effective for treating ashy dermatosis.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.